Plum Street Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Hold
1,218
– – 0.47% 43
2026
Q1
$1.12M Sell
1,218
-25
-2% -$25.3K 0.39% 47
2025
Q4
$1.34M Hold
1,243
– – 0.48% 45
2025
Q3
$948K Hold
1,243
– – 0.37% 49
2025
Q2
$969K Hold
1,243
– – 0.43% 45
2025
Q1
$1.03M Hold
1,243
– – 0.49% 42
2024
Q4
$960K Buy
1,243
+21
+2% +$17.4K 0.47% 46
2024
Q3
$1.08M Buy
1,222
+650
+114% +$584K 0.55% 40
2024
Q2
$518K Sell
572
-650
-53% -$520K 0.3% 49
2024
Q1
$1.08M Buy
1,222
+740
+154% +$527K 0.55% 40
2023
Q4
$281K Buy
+482
New +$281K 0.19% 57

Other funds holding LLY

Plum Street Advisors's LLY Position: Q2 2026 in Review

Plum Street Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 1,218 shares worth $1.46M. The position accounts for 0.47% of the portfolio, ranked #43.

Plum Street Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Plum Street Advisors held 1,218 shares of Eli Lilly worth $1.46M as of Q2 2026.
  • Plum Street Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.47% of Plum Street Advisors's portfolio in Q2 2026, its #43 holding.
  • Plum Street Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Plum Street Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.